SEARCH

SEARCH BY CITATION

References

  • 1
    Smith CM, Beasley GG, Cheng Y, Ormond DB, Spain PS. Annual Report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network. Washington, DC: US Department of Health and Human Services; Richmond, VA: United Network for Organ Sharing, 2000.
  • 2
    Muruve NA, Steinbecker KM, Luger AM. Are wedge biopsies of cadaveric kidneys obtained at procurement reliable? Transplantation 2000; 69: 23842388.
  • 3
    Karpinski J, Lajoie G, Cattran D, Fenton S, Zaltzman J, Cardella C, Cole E. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. Transplantation 1999; 67: 11621167.
  • 4
    Pokorna E, Vitko S, Chadimova M, Schuck O, Ekberg H. Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. Transplantation 2000; 69: 3643.
  • 5
    Kauffman HM, Bennett LE, McBride MA, Ellison MD. The expanded donor. Transplant Rev 1997; 11: 165190.
  • 6
    Holmquist M, Chabalewski F, Blount T, Edwards C, McBride V, Pietroski R. A critical pathway: guiding care for organ donors. Crit Care Nurse 1999; 19: 8498.
  • 7
    Mackersie RC, Bronsther OL, Shackford SR. Organ procurement in patients with fatal head injuries. The fate of the potential donor. Ann Surg 1991; 213: 143150.
  • 8
    Wheeldon DR, Potter CDO, Oduro A, Wallwork J, Large SR. Transforming the ‘unacceptable’ donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995; 14: 734742.
  • 9
    Zaroff JG, Rosengard BR, Armstrong WF et al. ASTS-AST Consensus Conference Report. Maximizing Use of Organs Recovered from the Cadaver Donor: Cardiac Recommendations. Crystal City, Virginia, USA: ASTS-AST; March 28–29, 2001.
  • 10
    Kron IL, Tribble CG, Kern JA et al. Successful transplantation of marginally acceptable thoracic organs. Ann Surg 1993; 217: 518524.
  • 11
    Zaroff JG, Solinger LL, Babcock WD. Temporal changes in donor left ventricular function: results of serial echocardiography. J Heart Lung Transplant 2000; 19: 76.
  • 12
    Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998; 17: 423429.
  • 13
    Jeevanandam V, Todd B, Regillo T, Hellman S, Eldridge C, McClurken J. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 1994; 13: 681687.
  • 14
    Orlowski JP, Spees EK. Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months. Transplant Proc 1993; 25: 1535.
  • 15
    Pennefather SH, Bullock. RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 1995; 59: 5862.
  • 16
    Cecka JM, Shoskes DA, Gjertson DW. Clinical impact of delayed graft function for kidney transplantation. Transplant Rev 2001; 15: 5767.
  • 17
    Hirata M, Cho YW, Cecka JM, Terasaki PI. Patient death after renal transplantation – an analysis of its role in graft outcome. Transplantation 1996; 62: 14791493.
  • 18
    Johnson CP, Kuhn EM, Hariharan S, Hartz AJ, Roza AM, Adams MB. Pre-transplant identification of risk factors that adversely affect length of stay and charges for renal transplantation. Clin Transplant 1999; 13: 168175.DOI: 10.1034/j.1399-0012.1999.130203.x
  • 19
    Kauffman HM, McBride MA, Graham WK, Wolf JS, Ellison MD, Daily OP. United Network for Organ Sharing donor data update, 1988–95. Transplant Proc 1997; 29: 122124.
  • 20
    Cho YW, Cecka JM. Organ procurement organization and transplant center effects on cadaver renal transplant outcomes. In: Cecka JM, Terasaki PI, eds. Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory; 1996. p. 427.
  • 21
    Shafer T, Huenke M, Wolff S et al. The Texas Nondonor Hospital Project: a preliminary report on the impact of inhouse coordinators on organ donation rates in nondonor hospitals. Transplant Proc 1997; 29: 32613262.
  • 22
    Gortmaker SL, Beasley CL, Sheehy E et al. Improving the request process to increase family consent for organ donation. J Transplant Coord 1998; 8: 210217.
  • 23
    Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 2000; 70: 17471751.